Loading page…

Lactose India Ltd (LACTOSE) · mywealthgrid

About

Lactose India Ltd operates in Pharmaceuticals within the Healthcare sector.

Face value: ₹10

Market cap

₹133 Cr

P/E

—

P/B

2.0×

Dividend yield

ROE

9.8%

ROCE

15.1%

Debt / equity

0.95

OPM

11.3%

EPS (TTM)

₹-1.9

Book value

₹51.5

52-week high

₹129.9

52-week low

₹78.2

₹105.4-16.3%1Y

Beta

0.75

Damps index moves

Volatility (1y)

52.5%

Annualised, daily returns

RSI (14)

58.8

Neither overbought nor oversold

Rel. strength (1y)

-24.8%

Behind the market

Beta is measured against NIFTY 50 over three years of weekly returns — 1 moves with the index, above 1 amplifies it, below 1 damps it.

Quick read

rule-based

Pros

+Profit CAGR of 71.1% over the last 3 years
+Revenue CAGR of 36.1% over the last 5 years

Cons

No red flags triggered.

Research score

Structured signal from quality, growth, valuation and momentum.

45/100

Business quality: 28
Growth: 74
Valuation: 52
Momentum: 26

Revenue & net profit

₹ crore, by fiscal year

RevenuePAT

Margins

% of revenue, by fiscal year

OPMPAT margin

Peers

Comparable companies from the narrowest available industry classification.

Screen this industry Compare top 5 side-by-side

Loading peers…

Financials

Reported profit and loss, balance sheet, cash flow and growth history.

Annual Quarterly

Standalone figures · ₹ crore · years without a filed annual are summed from quarters

₹ Cr	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	34	35	31	41	40	35	46	66	114	116	163
COGS	-6	-5	-6	-8	-7	5	8	24	52	52	94
Gross profit	—	—	—	—	—	30	38	42	62	64	69
	31	30	31	39	38	24	26	30	43	47	51
	10	11	6	10	9	6	12	11	19	17	18
OPM %	28.5%	30.5%	17.8%	23.7%	22.5%	17.8%	26.7%	17.3%	16.7%	14.6%	11.3%
Depreciation	3	3	4	4	4	4	5	5	5	5	6
Interest	4	4	5	5	6	5	5	6	5	6	5
	1	1	1	0	0	0	1	1	1	1	1
Profit before tax	4	4	-3	1	0	-3	3	1	10	7	9
Tax	1	2	-1	-0	0	-1	1	0	3	2	3
Tax %	27.8%	36.9%	-51.6%	-18.5%	30%	-24.2%	22.7%	17.8%	29.8%	25.3%	29.7%
	3	3	-1	1	0	-2	2	1	7	5	6
PAT margin %	8.3%	7.8%	-4.3%	3.1%	0.2%	-7.1%	5.3%	1.8%	6%	4.4%	3.7%
EPS (₹)	3.3	3	-1.4	1.1	0.1	-2.4	2.1	1	5.4	4.1	4.8
EPS adjusted (₹)	—	3.1	-1.3	1.3	0.1	-2.2	2	1	5.4	4.1	4.8
Annual report	Annual report for Mar 2016	Annual report for Mar 2017	Annual report for Mar 2018	Annual report for Mar 2019	Annual report for Mar 2020	Annual report for Mar 2021	Annual report for Mar 2022	Annual report for Mar 2023	Annual report for Mar 2024	Annual report for Mar 2025	—

₹ Cr	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity capital	9	10	10	10	11	13	13	13	13	13
Reserves	13	22	24	24	24	27	28	35	46	52
	29	34	32	36	46	41	38	38	56	62
	33	17	16	14	8	10	22	16	19	57
Total equity & liabilities	84	83	82	84	88	90	101	101	133	183
	62	62	60	61	59	59	56	53	52	69
CWIP	1	0	1	0	4	0	—	10	0	0
Investments	0	0	0	0	1	1	0	0	0	0
	21	20	20	23	25	31	45	37	82	114
Total assets	84	83	82	84	88	90	101	101	133	183

Loading financials…

Ratios

Annual operating, return, leverage and working-capital ratios.

Standalone figures

Ratio	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	—	—	85.2%	83.5%	63.2%	54.7%	55%	42.3%
EBITDA margin %	23.7%	22.5%	17.8%	26.7%	17.3%	16.7%	14.6%	11.3%
EBIT margin %	14.8%	13.2%	5.3%	16.8%	10.2%	12.1%	9.9%	7.7%
PAT margin %	3.1%	0.2%	-7.1%	5.3%	1.8%	6%	4.4%	3.7%
Working capital
Receivable days	62	64	67	90	69	49	68	75
Inventory days	95	105	587	343	344	119	171	217
Payable days	—	—	153	195	275	59	74	146
NWC days	—	—	501	238	138	109	165	146
Leverage
Current ratio	1.46	1.74	1.69	1.53	1.41	1.4	1.28	1.1
Debt to EBITDA	3.29	3.99	7.33	3.34	3.37	2	3.32	3.35
Debt to equity	0.92	1.05	1.3	1.04	0.95	0.81	0.96	0.95
Interest coverage	1.2	1	0.4	1.6	1.2	2.8	2.1	2.7
Asset turnover	0.5	0.48	0.4	0.51	0.65	1.13	0.87	0.89
Return ratios
Return on assets %	1.6%	0.1%	-2.8%	2.7%	1.2%	6.7%	3.9%	3.3%
Return on capital employed %	9.2%	7.9%	2.9%	10.9%	9.9%	19.9%	15.9%	15.1%
Return on equity %	3.7%	0.2%	-7.1%	6.2%	3%	14.4%	8.8%	9.4%

Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.

Loading ratios…

Shareholding

Quarterly ownership, named holders, insider transactions and disclosed deals.

Quarterly Annual

Every quarter filed · % of equity

Holder (%)	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	53.77%	53.66%	53.65%	53.65%	53.65%	53.65%	53.65%	53.65%	53.65%	53.65%	53.65%	53.65%
FII	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
	0.62%	0.62%	0.62%	0.62%	0.62%	0.62%	0.62%	0.62%	0.62%	0.62%	0.62%	0.62%
Government	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
	45.61%	45.72%	45.73%	45.73%	45.73%	45.73%	45.73%	45.73%	45.73%	45.73%	45.73%	45.73%
No. of shareholders	—	—	—	—	—	—	—	—	16,810	16,770	16,670	16,554

Promoter holding down 0.12 percentage points since Sep 2023.

1 deal · 29 Feb 2024 – 29 Feb 2024

Date	Client	Type	Venue	Side	Quantity	Price	Value
29 Feb 2024	ANKIT AGARWAL	Bulk	BSE	Sell	86,562	₹147.90	₹1.28 Cr

1–1 of 1

1 / 1

Bulk deals are a client trading over 0.5% of the equity in a session, aggregated across their trades; block deals are single negotiated trades in the exchange’s block window. Each is reported by the exchange it was crossed on, so NSE and BSE rows are separate trades rather than the same trade twice.

Mr. ATUL MAHESHWARIExecutive Director-Chairperson-MD
Mrs. SANGITA MAHESHWARIExecutive Director
Mr. CHANDRAMOHAN BHAGAVATULANon-Executive - Independent Director
Mr. NANDAN SRINATHNon-Executive - Independent Director
Mr. KISHOR PATELNon-Executive - Independent Director
Mr. Ritesh PandeyCompany Secretary & Compliance Officer

Current officeholders as filed with BSE. A person holding two offices is listed once per office.

Loading shareholding…

F&O

Current futures and options contracts with compact option-chain pages.

Not in the F&O segment

Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.

Loading f&o…

Fund holders

Mutual-fund schemes that disclosed a holding in the company.

No fund holdings on record

No scheme among the 32 fund houses on record reported a position in Lactose India Ltd. Portfolios are published monthly by each AMC; coverage is still partial.

Loading fund holders…

Documents

Annual reports, exchange filings, offer documents, ratings and earnings-call material.

Announcements

Annual reports

Credit ratings

Documents link to external sources (exchange filings, company investor pages).

Loading documents…

Events

Upcoming dates and the company’s corporate-action history.

1

Board meeting to consider results11 Aug 2026

Loading events…

Announcements

Latest exchange announcements, filings and downloadable documents.

1 month 3 months 6 months 1 year All

34 announcementsExport CSV

1 Oct 2026, 7:19 pmAGM/EGM

Disclosure Of Voting Results Of The Of 35Th Annual General Meeting Of Lactose India Limited (''Company'') Held On 30Th September, 2026

AGM PDF

1 Oct 2026, 7:14 pmAGM/EGM

Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

AGM PDF

30 Sept 2026, 4:55 pmCompany Update

Announcement under Regulation 30 (LODR)-Change in Management

Change in Management PDF

30 Sept 2026, 4:48 pmAGM/EGM

Shareholder Meeting / Postal Ballot-Outcome of AGM

AGM PDF

29 Sept 2026, 6:48 pmInsider Trading / SAST

Closure of Trading Window

Closure of Trading Window PDF

8 Sept 2026, 1:14 pmCompany Update

Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Publication PDF

7 Sept 2026, 7:12 pmCorp. Action

Lactose India Ltd - 524202 - Intimation For 35Th Annual General Meeting (AGM), Book Closure And Fixation Of Cut-Off Date For E-Voting, Period Of Remote E-Voting For The Financial Year 2025-2026.

Book Closure PDF

7 Sept 2026, 7:06 pmAGM/EGM

Shareholders Meeting - AGM On Wednesday 30Th September 2026

AGM PDF

Date	Category	Subject	Filing
1 Oct 2026, 7:19 pm	AGM/EGM AGM	Disclosure Of Voting Results Of The Of 35Th Annual General Meeting Of Lactose India Limited (''Company'') Held On 30Th September, 2026	PDF
1 Oct 2026, 7:14 pm	AGM/EGM AGM	Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

Loading announcements…

Company	Mkt Cap	EV	Revenue	EBITDA	OPM	PAT	NPM	ROCE	ROE	WC Days
Torrent Pharmaceuticals LimitedTORNTPHARMTORNTPHARM	₹1,61,325 Cr	₹1,76,123 Cr	₹15,723 Cr	₹5,191 Cr	32.6%	₹2,181 Cr	15.3%	14.5%	27.1%	163
Zydus Lifesciences LimitedZYDUSLIFEZYDUSLIFE	₹1,14,284 Cr	₹1,26,053 Cr	₹28,592 Cr	₹8,316 Cr	31.2%	₹4,513 Cr	18.9%	23.4%	19.7%	212
Laurus Labs LimitedLAURUSLABSLAURUSLABS	₹1,07,176 Cr	₹1,09,573 Cr	₹7,270 Cr	₹2,034 Cr	26.1%	₹1,093 Cr	13.1%	21.3%	18.2%	263
Mankind Pharma LimitedMANKINDMANKIND	₹1,04,696 Cr	₹1,11,007 Cr	₹14,738 Cr	₹3,827 Cr	25.3%	₹2,068 Cr	13.6%	14.2%	12.5%	117
Aurobindo Pharma LimitedAUROPHARMAAUROPHARMA	₹97,389 Cr	₹1,05,065 Cr	₹34,935 Cr	₹7,085 Cr	20.3%	₹3,713 Cr	10.4%	14.7%	9.9%	252
Lupin LimitedLUPINLUPIN	₹92,866 Cr	₹98,777 Cr	₹29,967 Cr	₹9,538 Cr	31.5%	₹5,529 Cr	19.2%	34.2%	26.9%	181
Glenmark Pharmaceuticals LimitedGLENMARKGLENMARK	₹65,781 Cr	₹65,781 Cr	₹17,737 Cr	₹4,797 Cr	26.9%	₹1,496 Cr	8%	37.8%	0%	83
Alkem Laboratories LimitedALKEMALKEM	₹62,431 Cr	₹64,055 Cr	₹15,081 Cr	₹3,032 Cr	20.4%	₹2,158 Cr	16%	21.5%	17.8%	152
Biocon LimitedBIOCONBIOCON	₹60,413 Cr	₹75,238 Cr	₹17,321 Cr	₹3,536 Cr	20.4%	₹495 Cr	2.2%	3.9%	1.4%	85
Abbott India LimitedABBOTINDIAABBOTINDIA	₹56,901 Cr	—	₹4,310 Cr	₹921 Cr	27.3%	₹691 Cr	22.4%	44.1%	34.5%	110
Ipca Laboratories LimitedIPCALABIPCALAB	₹49,299 Cr	₹50,003 Cr	₹10,126 Cr	₹2,232 Cr	20.5%	₹1,310 Cr	12.3%	17.8%	15.2%	308
Gland Pharma LimitedGLANDGLAND	₹47,428 Cr	₹47,671 Cr	₹6,725 Cr	₹1,751 Cr	25.3%	₹1,129 Cr	16%	14.8%	10.5%	255

₹ Cr	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	8	0	5	7	2	8	8	9	-0	6
	-5	-2	-2	-3	-6	-1	-1	-2	-16	-10
	-3	4	-5	-4	5	-8	-8	-6	19	1
Net cash flow	-0	3	-2	1	1	-0	-1	1	3	-4
Free cash flow	4	-2	3	4	-3	7	6	—	—	-5
CFO / Operating profit %	70.5%	2.9%	51.3%	82.2%	34.9%	69%	69.3%	46%	-1.7%	30.3%

Lactose India Ltd

Lactose India Ltd

About

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Ratios

Shareholding

F&O

Not in the F&O segment

Fund holders

No fund holdings on record

Documents

Announcements

Annual reports

Credit ratings

Events

1

Announcements

Not in the F&O segment

Announcements

Annual reports

Credit ratings

1

No fund holdings on record

Compounded sales growth

Compounded profit growth

Stock price CAGR

Return on equity

Lactose India Ltd

Lactose India Ltd

About

Risk & technicals

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Profit & loss

Balance sheet

Ratios

Ratio timeline

Shareholding

Quarterly record

Bulk & block deals

Board and management

F&O

Not in the F&O segment

Fund holders

No fund holdings on record

Documents

Announcements

Annual reports

Credit ratings

Events

Board meetings1

Announcements

Not in the F&O segment

Announcements

Annual reports

Credit ratings

Board meetings1

Ratio timeline

Quarterly record

Bulk & block deals

Board and management

No fund holdings on record

Profit & loss

Balance sheet

Cash flow

Compounded returns

Compounded sales growth

Compounded profit growth

Stock price CAGR

Return on equity

1

1